Papoutsaki M
Adalimumab for the treatment of severe psoriasis and psoriatic arthritis
Expert Opin Biol Ther. 2008 Mar;8(3):363-70

Revicki D
Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis.
Br J Dermatol. 2008 Mar;158(3):549-57. Epub 2007 Nov 28

Saurat JH
Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION).
Br J Dermatol. 2008 Mar;158(3):558-66. Epub 2007 Nov 28